Table of contents
1.2 scope of study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.3 Market Structure:
2. Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3. Market dynamics
3.4 Macroeconomic Indicators
4. Market factor analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Ureteral Obstruction Market, by Type
6. Global Ureteral Obstruction Market, By Diagnosis
6.2 Computed Tomography (CT)
6.3 Magnetic Resonance Imaging (MRI)
6.4 Voiding Cystourethrography (VCUG)
6.7 Blood and Urine Tests
6.8 Bladder Catheterization
7. Global Ureteral Obstruction Market, By Treatment
7.1.1 Ureteral Stent
7.1.3 Open Laparoscopy
7.1.5 Robot-Assisted Laparoscopy
7.2.2 Pain Killers
8. Global Ureteral Obstruction Market, By Equipment
8.2.1 Diagnostic Reagents
8.2.2 Urinary Sample Collectors
9. Global U reteral Obstruction Market, By End Users
9.1 Hospitals and Clinics
9.3 Home Care
10. Global Ureteral Obstruction Market, By Region
10.1 North America
10.4 Middle East & Africa
11. Competitive landscape
11.1 Major Strategies Adopted By Market Players
11.1.1 Strategic Partnership
11.1.2 Merger & Acquisition
12. Company profile
12.1 C. R. Bard, Inc.
12.1.2 Product Overview
12.1.4 Key Developments
12.2 Boston Scientific Corporation
12.2.2 Product Overview
12.2.4 Key Developments
12.3 Cook Medical Inc.
12.3.2 Product Overview
12.3.4 Key Development
12.4 Medline Industries, Inc.
12.4.2 Product Overview
12.4.4 Key Developments
12.5 Coloplast A/S
12.5.2 Product Overview
12.5.4 Key Developments
12.6 DISA Vascular
12.6.2 Product Overview
12.6.4 Key Developments
12.7 Terumo Europe NV
12.7.2 Product Overview
12.7.4 Key Developments
12.8.2 Product Overview
12.8.4 Key Developments
12.9 Novartis AG
12.9.2 Product Overview
12.9.4 Key Developments
12.10 Johnson and Johnson
12.10.2 Product Overview
12.10.4 Key Developments
13.1 Key Findings
13.1.1 From Ceo’s Viewpoint
13.1.2 Unmet Needs Of The Market
13.2 Key Companies To Watch
13.3 Prediction Of Ureteral Obstruction Treatment Industry
Ureteral Obstruction Market Overview:
Ureteral obstruction or urinary tract obstruction is a condition of blockage of urine through the urinary tract, which may be complete or partial. In ureteral obstruction the urine may refluxes backward into your kidneys. Ureteral obstruction is curable, but if not treated, can lead to loss of kidney function, sepsis and eventually death. Other severe consequences are kidney stones, and infection of the urinary tract. Mild symptoms generally in partial blockage are pain on one side, abnormal urine flow and frequent , acute stinging pain etc. Ureteral obstruction are caused by injuries such as a pelvic fracture, ureter, kidneys, bladder or colon cancers, kidney stones in ureter etc. Nervous system disorders in which nerves responsible for bladder control cease to function properly, also cause obstructive uropathy. Some drugs such as those used to control overactive bladder can also cause obstructive uropathy. Other causes are enlarged prostate,
The diagnosis of urinary tract obstruction are ultrasound, bladder catheterization, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), voiding cystourethrography (VCUG), endoscopy, blood and urine tests etc. The ureteral obstruction market is driven by factors such as congenital abnormalities, low demand flexibility of the treatment due to serious consequences of the defect, increasing penetration of healthcare etc. The market constraints are cost of the treatment, threat of infection and pain during surgery etc.
Considering all these factors, the ureteral obstruction market is expected to reach $ 22.5 billion by the end of 2023, ureteral obstruction market is projected to growing at a CAGR of ~ 8.5 % during 2017-2023.
Sources: Mayo Clinic, MRFR Analysis.
Figure 1 Ureteral obstruction Market by End Users, 2016 (% Market Share)
The ureteral obstruction market is segmented on the basis of type, diagnosis, treatment, equipment and end users. Based on type, the ureteral obstruction market has been segmented as acute and chronic. Based on diagnosis, the ureteral obstruction market has been segmented as ultrasound, bladder catheterization, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), voiding cystourethrography (VCUG), pyelography, endoscopy, blood and urine tests and others. Based on the treatment, the ureteral obstruction market has been segmented as surgery (ureteral stent, nephrostomy, open laparoscopy, catheterization, robot-assisted laparoscopy, others) and drugs (antibiotics, pain killers, others). Based on the equipment, the market has been segmented as devices (catheters, stents, others) and consumables (diagnostic reagents, urinary sample collectors, others) and others. Based on the end users, the market has been segmented as hospitals and clinics, research, others.
US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the ureteral obstruction market. The presence of large device companies in the developed regions is also a major driver of the ureteral obstruction market. Europe is the second largest market due to large disposable income and rising awareness regarding the health hazards of this condition. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.
Key players of Ureteral Obstruction Market:
Key players profiled in the ureteral obstruction market report are C. R. Bard, Inc., Boston Scientific Corporation, Cook Medical Inc., Medline Industries, Inc., Coloplast A/S, DISA Vascular, Terumo Europe NV, Medtronic, Novartis AG, Johnson and Johnson and others.
The report for Ureteral obstruction market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current ureteral obstruction market scenario which includes past and estimated future ureteral obstruction market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Diagnosis, Treatment, Equipment and End Users|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||C. R. Bard, Inc., Boston Scientific Corporation, Cook Medical Inc., Medline Industries, Inc., Coloplast A/S, DISA Vascular, Terumo Europe NV, Medtronic, Novartis AG, Johnson and Johnson and others|
|Key Market Opportunities||New product launches and R&D Amongst major key Players|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Ureteral obstruction market is expected to exhibit a CAGR of 8.5% from 2017 to 2023.
Ureteral obstruction market size can reach USD 22.5 billion by 2023.
The high chances of kidney diseases caused by non-treatment of ureteral obstruction is the major driver of the global ureteral obstruction market.
High treatment costs and threat of infections during surgery can hamper the global ureteral obstruction market.
North Americas can dominate the global ureteral obstruction market till 2023.
Novartis AG, Cook Medical Inc., DISA Vascular, Medtronic, C. R. Bard, Inc., Johnson and Johnson, Medline Industries, Inc., Boston Scientific Corporation, Coloplast A/S, and Terumo Europe NV are notable players of the global ureteral obstruction market.